Latest News and Press Releases

HANOVER, Md, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...

Hong Kong, Jan. 03, 2025 (GLOBE NEWSWIRE) -- SOLOWIN HOLDINGS (Nasdaq: SWIN) (“SOLOWIN” or the “Company”), a leading financial services firm providing high-net-worth and institutional investors with...

Chicago, Oct. 15, 2024 (GLOBE NEWSWIRE) --  Entara, a security-first eXtended Service Provider, was recently named to the Channel Futures 2024 Next Generation list recognizing fast-growing managed...

New York, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Overview The Global Next Generation Cancer Diagnostics Market size is expected to reach USD 19.1 billion by 2024. It is further anticipated to reach a...

Phase 2 trial with NGC-Cap in breast cancer underway NGC-Cap Phase 1b trial demonstrated a favorable safety profile with preliminary anti-tumor activity Preclinical studies demonstrated NGC-Iri...

Mr. David Pruner elaborates on preparing students and future entrepreneurs to solve dual issues of finding more energy for the world and at the same time lowering carbon intensity SANTA CLARITA,...

HANOVER, MD, March 25, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...

The new development offers high performance and real time artificial intelligence deep learning inference Ness Ziona, Israel, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd....

HANOVER, MD, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...

HANOVER, MD, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company now focused on developing the next...